Epitalon acetat CAS:307297-40-1

Epithalon was first discovered in the late 1980's by Prof. Vladimir Khavinson from St. Petersburg, Rusija. It has been studied extensively ever since. It is known by several names, including Epitalon, Epitalon, Epithalone, Epithalamin and Epithalamine. Since all the patents are held by the Russian inventor there is not much interest for this tetra-peptide from the western big pharma industry. This makes the substance fairly unknown in the west due to the absence of marketing usually seen with big pharma products. In Russia it is currently in clinical studies and shows prospective results as treatment for liver disorders, neuropathology, psychiatry and geriatrics.

Epitalon zmanjšuje s starostjo povezane spremembe v imunskem in nevroendokrinem sistemu, zmanjša pojavnost ponavljajočih se okužb in kroničnih bolezni. Dolgoročna klinična preskušanja so pokazala, da pri bolnikih s starostno povezano patologijo Epithalamin odpravlja neravnovesje v prooksidacijskih in antioksidacijskih sistemih.. Rezultati 12-mesečnega zdravljenja z Epithalonom pri bolnikih z znaki pospešenega staranja so pokazali normalizirajoč učinek na metabolizem in stanje različnih funkcionalnih sistemov.. Elevated uric acid, alkalna fosfataza in holesterol pri starejših bolnikih sta se po tem normalizirala 10 days of treatment, in je ostal stabilen nekaj mesecev po tem.